 PHILADELPHIA, Aug. 04, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. Nasdaq: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, acknowledges today with great sorrow that Tadataka Tachi Yamada, M.D., founder and chairman of the board for Passage Bio, passed away unexpectedly on August 3, 2021. 